المؤلفون: Fernandez-Perez, Maria P, Perez-Navarro, Enrique, Alonso-Gordoa, Teresa, Conteduca, Vicenza, Font, Albert, Vazquez-Estevez, Sergio, Gonzalez-del-Alba, Aranzazu, Wetterskog, Daniel, Antonarakis, Emmanuel S, Mellado, Begona, Fernandez-Calvo, Ovidio, Mendez-Vidal, Maria J, Climent, Miguel A, Duran, Ignacio, Gallardo, Enrique, Rodriguez Sanchez, Angel, Santander, Carmen, Saez, Maria, Puente, Javier, Tudela, Julian, Martinez, Alberto, Lopez-Andreo, Maria J, Padilla, Jose, Lozano, Rebeca, Hervas, David, Luo, Jun, de Giorgi, Ugo, Castellano, Daniel, Attard, Gerhardt, Grande, Enrique, Gonzalez-Billalabeitia, Enrique

المصدر: Prostate , 83 (4) pp. 376-384. (2023)

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Endocrinology & Metabolism, Urology & Nephrology, AR gain, AR-V7, CTCs, enzalutamide, prostate cancer, TMPRSS2-ERG, CIRCULATING TUMOR-CELLS, GENE STATUS, ANDROGEN RECEPTOR, CLINICAL-TRIALS, ABIRATERONE, SURVIVAL, SURROGATE, TMPRSS2, FUSION, MEN

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10164231/1/A%20correlative%20biomarker%20study%20and%20integrative%20prognostic%20model.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10164231Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10164231/1/A%20correlative%20biomarker%20study%20and%20integrative%20prognostic%20model.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10164231Test/

المؤلفون: Fernandez-Perez, María P., Perez-Navarro, Enrique, Alonso-Gordoa, Teresa, Conteduca, Vincenza, Font, Albert, Vázquez-Estévez, Sergio, González-del-Alba, Aránzazu, Wetterskog, Daniel, Antonarakis, Emmanuel S., Mellado, Begona, Fernandez-Calvo, Ovidio, Méndez-Vidal, María J., Climent, Miguel Ángel, Duran, Ignacio, Gallardo, Enrique, Rodriguez Sanchez, Angel, Santander, Carmen, Sáez, Maria I., Puente, Javier, Tudela, Julian, Martínez, Alberto, López-Andreo, Maria J., Padilla, José, Lozano, Rebeca, Hervas, David, Luo, Jun, De Giorgi, Ugo, Castellano, Daniel, Attard, Gerhardt, Grande, Enrique, Gonzalez-Billalabeitia, Enrique, Universitat Autònoma de Barcelona

مصطلحات موضوعية: AR gain, AR-V7, CTCs, Enzalutamide, Prostate cancer, TMPRSS2-ERG

وصف الملف: application/pdf

العلاقة: Ministerio de Economía y Competitividad BA16/00038; Instituto de Salud Carlos III PI18/00883; The Prostate; Vol. 83 (december 2022); https://ddd.uab.cat/record/281329Test; urn:10.1002/pros.24469; urn:oai:ddd.uab.cat:281329; urn:pmcid:PMC10107622; urn:pmc-uid:10107622; urn:pmid:36564933; urn:oai:pubmedcentral.nih.gov:10107622

الإتاحة: https://ddd.uab.cat/record/281329Test